CIBC World Markets’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$491K Buy
+7,729
New +$481K ﹤0.01% 836
2025
Q2
$476K Sell
14,394
-10,967
-43% -$381K ﹤0.01% 896
2025
Q1
$1.02M Buy
25,361
+14,665
+137% +$674K 0.01% 684
2024
Q4
$503K Buy
+10,696
New +$555K ﹤0.01% 735

Other funds holding CYTK

CIBC World Markets's CYTK Position: Q4 2025 in Review

CIBC World Markets opened a new position in Cytokinetics (CYTK) in Q4 2025: 7,729 shares worth $491K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in CYTK as recently as Q2 2025.

CIBC World Markets first reported a position in CYTK in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.02M in Q1 2025. 431 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

  • CIBC World Markets held 7,729 shares of Cytokinetics worth $491K as of Q4 2025.
  • Cytokinetics was a new CIBC World Markets position in Q4 2025.
  • Cytokinetics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #836 holding.
  • CIBC World Markets first reported a position in Cytokinetics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Cytokinetics position peaked at $1.02M in Q1 2025.
  • 431 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.